Arbutus Biopharma
ABUS
#7151
Rank
ยฃ0.47 B
Marketcap
ยฃ3.10
Share price
1.49%
Change (1 day)
-10.13%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2026 (TTM): ยฃ0.11 Billion

According to Arbutus Biopharma 's latest financial reports the company's current earnings are ยฃ0.18 Billion. In 2025 the company made an earning of -ยฃ25.38 Million, an increase over its 2024 earnings that were of -ยฃ52.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ0.11 B-555.93%
2025 -ยฃ25.38 Million-52.09%
2024 -ยฃ52.97 Million-4.02%
2023 -ยฃ55.19 Million12.05%
2022 -ยฃ49.25 Million-14.74%
2021 -ยฃ57.77 Million19.61%
2020 -ยฃ48.29 Million-61.69%
2019 -ยฃ0.13 Billion171.23%
2018 -ยฃ46.47 Million-43.58%
2017 -ยฃ82.37 Million-77.77%
2016 -ยฃ0.38 Billion532.77%
2015 -ยฃ58.57 Million99.05%
2014 -ยฃ29.43 Million175.82%
2013 -ยฃ10.67 Million-143.7%
2012 ยฃ24.41 M-399.11%
2011 -ยฃ8.17 Million-39.03%
2010 -ยฃ13.39 Million100.55%
2009 -ยฃ6.68 Million-28.56%
2008 -ยฃ9.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-ยฃ1.64 Million-101.41% Bahamas
NRC Health
NRC
ยฃ11.2 M-90.34%๐Ÿ‡บ๐Ÿ‡ธ USA